bretylium   Click here for help

GtoPdb Ligand ID: 7130

Synonyms: ASL-603 | bretylium tosylate | Bretylol®
Approved drug
bretylium is an approved drug
Compound class: Synthetic organic
Comment: Bretylium is a substrate for the noradrenaline transporter so it accumulates inside nerve terminals which have this transporter. This accumulation underlies its inhibitory action on the sympathetic nervous system. Bretylium tosylate is no longer available in the US.
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: bretylium

2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 0
Hydrogen bond donors 0
Rotatable bonds 3
Topological polar surface area 0
Molecular weight 242.05
XLogP 2.8
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES CC[N+](Cc1ccccc1Br)(C)C
Isomeric SMILES CC[N+](Cc1ccccc1Br)(C)C
InChI InChI=1S/C11H17BrN/c1-4-13(2,3)9-10-7-5-6-8-11(10)12/h5-8H,4,9H2,1-3H3/q+1
No information available.
Summary of Clinical Use Click here for help
Used for emergency treatment of ventricular tachycardia and ventricular fibrillation. However, there is no information regarding approval for clinical use of this drug on the US FDA website. Other national approval agencies may have granted marketing authorisation
Mechanism Of Action and Pharmacodynamic Effects Click here for help
May act though inhibition of voltage-gated K+ channels or by binding extracellularly to Na+/K+-ATPases.